Patrick Hwu
Impact in
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 0.02%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 240
- Cancer Immunotherapy and Biomarkers 165
- CAR-T cell therapy research 45
- Cutaneous Melanoma Detection and Management 36
- Immunology 141
- Immunotherapy and Immune Responses 118
- T-cell and B-cell Immunology 33
- Co-authors
- Steven A. Rosenberg (39 shared papers)Suzanne Louise Topalian (18 shared papers)Douglas J. Schwartzentruber (18 shared papers)James Chih‐Hsin Yang (10 shared papers)Richard Mark Sherry (11 shared papers)Nicholas P. Restifo (20 shared papers)Claudia A. Seipp (11 shared papers)Donald Edward White (11 shared papers)
- Journals
- Clinical Cancer Research (38 papers)Journal for ImmunoTherapy of Cancer (26 papers)Journal of Immunotherapy (18 papers)Annals of Oncology (15 papers)The Journal of Immunology (15 papers)
- Partner nations
- United StatesItalyChina
In The Last Decade
Patrick Hwu
401 papers receiving 60.9k citations
Patrick Hwu's Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 31.7k
- Immunology 15.7k
- Cancer Research 2.7k
- Molecular Biology 10.8k
- Pulmonary and Respiratory Medicine 5.1k
Countries citing papers authored by Patrick Hwu
This map shows the geographic impact of Patrick Hwu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hwu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hwu more than expected).
Fields of papers citing papers by Patrick Hwu
This network shows the impact of papers produced by Patrick Hwu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hwu. The network helps show where Patrick Hwu may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Hwu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 404 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer Hit paper breakdown → | 2012 | 6724 |
| 2 | Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients Hit paper breakdown → | 2017 | 3860 |
| 3 | Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes Hit paper breakdown → | 2002 | 2329 |
| 4 | A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer Hit paper breakdown → | 2003 | 2282 |
| 5 | B cells and tertiary lymphoid structures promote immunotherapy response Hit paper breakdown → | 2020 | 2032 |
| 6 | Chimeric antigen receptor T-cell therapy — assessment and management of toxicities Hit paper breakdown → | 2017 | 1980 |
| 7 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Hit paper breakdown → | 1998 | 1552 |
| 8 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Hit paper breakdown → | 2003 | 1352 |
| 9 | Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy Hit paper breakdown → | 2015 | 1299 |
| 10 | PD-L1 Expression in Triple-Negative Breast Cancer Hit paper breakdown → | 2014 | 1158 |
| 11 | Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy Hit paper breakdown → | 2016 | 1085 |
| 12 | A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer Hit paper breakdown → | 2006 | 1070 |
| 13 | A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade Hit paper breakdown → | 2018 | 1038 |
| 14 | Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade Hit paper breakdown → | 2016 | 819 |
| 15 | BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma Hit paper breakdown → | 2013 | 813 |
| 16 | Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response Hit paper breakdown → | 2021 | 734 |
| 17 | gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma Hit paper breakdown → | 2011 | 730 |
| 18 | Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance Hit paper breakdown → | 2017 | 708 |
| 19 | Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma Hit paper breakdown → | 2018 | 689 |
| 20 | T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity Hit paper breakdown → | 2009 | 668 |
About Patrick Hwu
Patrick Hwu is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 404 papers that have together received 62.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (165 papers), Immunotherapy and Immune Responses (118 papers), CAR-T cell therapy research (45 papers), Melanoma and MAPK Pathways (44 papers), Cutaneous Melanoma Detection and Management (36 papers), T-cell and B-cell Immunology (33 papers), Brain Metastases and Treatment (12 papers) and Virus-based gene therapy research (11 papers). The work is most often cited by research in Oncology (31.7k citations), Immunology (15.7k citations), Cancer Research (2.7k citations), Molecular Biology (10.8k citations) and Pulmonary and Respiratory Medicine (5.1k citations). Patrick Hwu has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Steven A. Rosenberg, Suzanne Louise Topalian, Douglas J. Schwartzentruber, James Chih‐Hsin Yang, Richard Mark Sherry, Nicholas P. Restifo, Claudia A. Seipp, Donald Edward White, Seth M. Steinberg and Linda J. Rogers-Freezer. Their work appears in journals such as Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Journal of Immunotherapy, Annals of Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.